Treatment of Blepharitis
Begin with daily warm compresses and eyelid hygiene as first-line therapy for all blepharitis patients, then add topical antibiotics (bacitracin or erythromycin ointment) for anterior blepharitis or oral tetracyclines (doxycycline) for posterior blepharitis/meibomian gland dysfunction if symptoms persist after 2-4 weeks. 1, 2
First-Line Treatment: Eyelid Hygiene (All Patients)
- Apply warm compresses for several minutes once or twice daily to soften adherent material and warm meibomian secretions 1, 2
- Perform gentle eyelid cleansing using diluted baby shampoo or commercially available eyelid cleaners once or twice daily 2, 3
- Consider hypochlorous acid 0.01% eye cleaners which have strong antimicrobial effects for both anterior and posterior blepharitis 2, 3
- Add vertical eyelid massage for posterior blepharitis/MGD to help express meibomian secretions 3
- Use artificial tears (preferably preservative-free if used >4 times daily) to manage associated dry eye symptoms 2, 3
Critical caveat: Patients must understand this is a chronic condition requiring long-term management—symptoms typically recur when treatment is discontinued 1, 3
Second-Line Treatment: Topical Antibiotics (Anterior Blepharitis)
If inadequate response to eyelid hygiene after 2-4 weeks:
- Apply bacitracin or erythromycin ointment to eyelid margins one or more times daily or at bedtime for a few weeks 1, 2
- Rotate different antibiotic classes intermittently to prevent development of resistant organisms 1, 2, 3
- Consider topical azithromycin 1% solution applied twice daily for 2 days, then once daily for 12 days for moderate to severe chronic blepharitis 2
Important pitfall: Long-term continuous antibiotic use leads to resistant organisms—use intermittently based on symptom severity 1, 2, 3
Oral Antibiotics (Posterior Blepharitis/MGD)
For posterior blepharitis/MGD not adequately controlled by eyelid cleansing or meibomian gland expression:
- Doxycycline, minocycline, or tetracycline given daily and tapered after clinical improvement 1, 3
- For women of childbearing age and children: Use oral erythromycin (30-40 mg/kg divided over 3 doses for 3 weeks, then twice daily for 4-6 weeks) or azithromycin (5 mg/kg daily for 2 months in children) 1
- Alternative oral azithromycin regimen for adults: 500 mg daily for 3 days in three cycles with 7-day intervals, or 1 g per week for 3 weeks 1, 2, 3
Critical FDA warning: Oral azithromycin may cause cardiac electrical abnormalities with serious heart rhythm irregularities, particularly in patients with high baseline cardiovascular disease risk—assess cardiovascular risk before prescribing 1, 2, 3
Anti-Inflammatory Therapy
- Brief course of topical corticosteroids (applied several times daily) for significant eyelid or ocular surface inflammation, marginal keratitis, or phlyctenules 1, 3
- Prefer loteprednol etabonate or fluorometholone phosphate over dexamethasone due to lower risk of intraocular pressure elevation and cataract progression 1, 3
- Taper and discontinue once inflammation is controlled, then use intermittently to maintain comfort 1
- Consider topical cyclosporine for some patients with posterior blepharitis 1, 3
Major caveat: Use minimal effective corticosteroid dose and avoid long-term therapy—monitor for increased intraocular pressure and cataract formation 1
Newer FDA-Approved Options
- Topical perfluorohexyloctane (FDA approved 2023) prevents tear evaporation and improves symptoms and corneal staining in patients with associated dry eye disease after 8 weeks 1, 3
- Selenium sulfide showed significant improvements in meibomian gland function and Ocular Surface Disease Index scores in phase 2 trials for MGD 1
Special Considerations for Rosacea-Associated Blepharitis
- High-quality evidence supports topical azelaic acid, topical ivermectin, brimonidine, doxycycline, and isotretinoin for systemic rosacea 1
- Oral tetracyclines (doxycycline, minocycline) are particularly effective for ocular rosacea with blepharitis 1
- Tea tree oil at 50% concentration can be considered for Demodex-associated blepharitis in patients not improving with previous treatments 3
Adjunctive Therapies
- Omega-3 fatty acid supplementation has mixed evidence—one study showed improvement in tear break-up time and meibum score with 3000 mg daily, but a large NIH-funded trial showed no benefit over placebo for moderate to severe dry eye 1, 3
- In-office procedures such as vectored thermal pulsation or microblepharoexfoliation may be considered for recalcitrant cases 3
Pre-Surgical Management
Address moderate to severe blepharitis prior to intraocular surgery to reduce risk of postoperative endophthalmitis 2, 3
Pediatric Considerations
Evidence is limited: A Cochrane systematic review reported uncertainty regarding effectiveness of both topical and systemic treatments for blepharokeratoconjunctivitis in children due to lack of high-quality evidence—more clinical trials are needed 1, 2
Key Patient Education Points
- Warn patients about glaucoma risk: Those with advanced glaucoma should avoid aggressive lid pressure during warm compresses as it may increase intraocular pressure 1
- Emphasize chronicity: Complete cure is usually not possible; successful management depends on long-term treatment compliance 2, 3
- Caution about compress temperature: Avoid compresses that are too hot to prevent skin burns 3